EUVIMEDEUVIMED entdecken
Open Access · CC BY 4.0

Identification of high-performing antibodies for Moesin for use in Western Blot, immunoprecipitation, and immunofluorescence

Walaa Alshafie, Riham Ayoubi, Maryam Fotouhi, Kathleen Southern iD, Carl Laflamme iD, NeuroSGC/YCharOS collaborative group

F1000Research · 2023

DOI: 10.12688/f1000research.130126.3 ↗

Kurz gefasst

Fachartikel in der Zeitschrift F1000Research, 2023. Verfasst von Walaa Alshafie und 5 weiteren Autor:innen. Beteiligte Einrichtung: Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Quebec, H…. Hauptthemen laut MEDLINE: Cytoskeletal Proteins, Antibodies. Die Arbeit wurde bisher 11-mal zitiert (Crossref) und nennt 20 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: NIA NIH HHS, Ontario Genomics, Mitacs.

AbstractSchlagwörterBibliografische AngabenZitierenVerwandte Studien

Abstract (Originalsprache)

Moesin is a cytoskeletal adaptor protein, involved in the modification of the actin cytoskeleton, with relevance to Alzheimer’s Disease. Well characterized anti-Moesin antibodies would benefit the scientific community. In this study, we have characterized ten Moesin commercial antibodies in Western Blot, immunoprecipitation, and immunofluorescence using a standardized experimental protocol based on comparing read-outs in knockout cell lines and isogenic parental controls. These studies are part of a larger, collaborative initiative seeking to address antibody reproducibility by characterizing commercially available antibodies for human proteins and publishing the results openly as a resource for the scientific community. While use of antibodies and protocols vary between laboratories, we encourage readers to use this report as a guide to select the most appropriate antibodies for their specific needs.

Schlagwörter

MeSH-Schlagwörter (MEDLINE)

Cytoskeletal ProteinsAntibodiesHumansReproducibility of ResultsBlotting, WesternImmunoprecipitationFluorescent Antibody TechniqueMicrofilament Proteins

Stichwörter der Autor:innen

MSNMoesinUniprot ID P26038Western Blotantibody characterizationantibody validationimmunofluorescenceimmunoprecipitation

Substanzen

Cytoskeletal ProteinsAntibodiesmoesinMicrofilament Proteins

Autor:innen und Institutionen

  • Department of Neurology and Neurosurgery, Structural Genomics Consortium, The Montreal Neurological Institute, McGill University, Montreal, Quebec, H3A 2B4, Canada.

ORCID-Profile: Kathleen Southern, Carl Laflamme

Förderung

  • NIA NIH HHS
  • Ontario Genomics
  • Mitacs
  • National Institutes of Health
  • Genome Canada
  • National Institute of Aging

Zitieren

APA

Alshafie, W., Ayoubi, R., Fotouhi, M., Southern, K., Laflamme, C., & NeuroSGC/YCharOS collaborative group (2023). Identification of high-performing antibodies for Moesin for use in Western Blot, immunoprecipitation, and immunofluorescence. F1000Research. https://doi.org/10.12688/f1000research.130126.3

Vancouver

Alshafie W, Ayoubi R, Fotouhi M, Southern K, Laflamme C, NeuroSGC/YCharOS collaborative group. Identification of high-performing antibodies for Moesin for use in Western Blot, immunoprecipitation, and immunofluorescence. F1000Research. 2023. doi:10.12688/f1000research.130126.3

BibTeX
@article{Alshafie2023,
  author = {Alshafie, Walaa and Ayoubi, Riham and Fotouhi, Maryam and Southern, Kathleen and Laflamme, Carl and NeuroSGC/YCharOS collaborative group, NeuroSGC/YCharOS collaborative group},
  title = {Identification of high-performing antibodies for Moesin for use in Western Blot, immunoprecipitation, and immunofluorescence},
  journal = {F1000Research},
  year = {2023},
  doi = {10.12688/f1000research.130126.3}
}
Kostenlos starten →